BioSpace News Archive

Baxter International Inc. (NYSE:BAX), a global innovator in kidney care, announced today new data indicating the use of Baxter’s Sharesource remote patient management platform with an automated peritoneal dialysis (APD) cycler may improve the clinical effectiveness of home kidney patients care by extending their time on therapy by 3.4 months.

Endonovo Therapeutics Inc. (OTC-ENDV), a developer and distributor of Innovative Medical Devices is pleased to announce that it has appointed Garry Michael Kann as Head of Corporate Development to design, lead and execute its new corporate “build up strategy” of identifying and acquiring complementary specialty service providers in the construction industry.

Invectys, Inc. of Houston, Texas, a clinical stage immunotherapy company dedicated to the development of a next generation of therapies to meet the needs of cancer patients, today announced the appointment of Jian Cao, Ph.D., as Vice President, Pharmaceutical Development.

New products expand end-to-end levitation-based workflow with tissue dissociation and cell selection capabilities.

Vaxess Technologies, Inc., an innovative life sciences company developing a pipeline of shelf-stable and simple-to-apply vaccines on the MIMIX patch platform announced occupancy of a second new facility and significant additions to the leadership team.

Tricentis, a leader in test automation for modern cloud and enterprise applications, announced today the acquisition of Tx3 Services, a provider of automated quality and compliance software testing solutions for life sciences companies.

AltPep Corporation, a privately held biotechnology company developing early disease-modifying treatments and detection tools for amyloid diseases, today announced the U.S. Food and Drug Administration (FDA) granted the company Breakthrough Device designation for its SOBA-AD diagnostic in development for Alzheimer’s disease (AD).

Pacific GeneTech announces the appointment of Dr. Edward Fryar, Jr. to PGT’s Board of Directors. “We are very honored to have Dr. Fryar join our board. Ed brings to PGT decades of successful management, entrepreneurship and expertise in the poultry industry and his many years of academic research for the agriculture industry.

NEOGEN Corporation announced that it has added a ready-to-use formulation of their Synergize® disinfectant to their biosecurity portfolio.

Alcami, a U.S.-based pharmaceutical contract development and manufacturing organization, announced the addition of a 3,800 ft² Non-GMP Formulation Development Laboratory.